Publicly-traded company Precision BioSciences Inc. (NASDAQ:DTIL) had a closing price of $8.11 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $23.17, this means that the stock is underpriced by 65.0%. In the past 52 weeks the company’s stock price has moved within the range of $6.24 to $19.00.
This particular stock’s 5-day moving average is 6.93, its 20-day moving average is 6.74 and its 100-day moving average is 10.05. Precision BioSciences Inc. (DTIL) currently has 50.17M shares outstanding, which means that its market capitalization is $406.88M.
What Does Wall Street Say about Company?
When choosing stocks, many investors search for what Wall Street professionals think about the company first – like what the average rating is. At the moment, the average analyst rating for DTIL is Buy. Out of 6 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 6 rated it a Buy.
Understanding Profitability at Precision BioSciences Inc. (DTIL)
Taking a look at a public company’s Earnings per Share (EPS) is a good way of evaluating its profitability. In the most recent financial results released by Precision BioSciences Inc., for the quarter ending on 09/2019, the company posted EPS of -0.56. The average estimate of Wall Street analysts had projected -0.45.